A 38-year-old woman from Mumbai with a 3-year history of seropositive rheumatoid arthritis (RF and anti-CCP positive) presents with progressive joint destruction despite conventional DMARD therapy. A synovial biopsy from an inflamed knee joint is performed. Histological examination shows hyperplastic synovium with a dense infiltrate of CD4+ T cells, B cells, and plasma cells arranged in lymphoid aggregates with germinal centre-like structures. Numerous activated macrophages and fibroblasts are also present. Which of the following best describes the immunopathological process occurring in this synovial tissue?

Explanation

## Immunopathological Classification of Rheumatoid Arthritis ### RA as a Type III Hypersensitivity Reaction **Key Point:** Rheumatoid arthritis is fundamentally a **Type III (immune complex-mediated) hypersensitivity reaction** with a secondary Type IV (cell-mediated) component. The synovial inflammation is driven by immune complex deposition and complement activation. ### Pathological Sequence in RA ```mermaid flowchart TD A[B cell activation by Th17/Tfh cells]:::outcome --> B[Production of RF and anti-CCP antibodies]:::action B --> C[Formation of immune complexes]:::outcome C --> D[Deposition in synovial membrane and fluid]:::action D --> E[Complement activation via classical pathway]:::action E --> F[C3a and C5a generation]:::outcome F --> G[Recruitment of neutrophils and macrophages]:::action G --> H[Synovial inflammation and cytokine release]:::action H --> I[TNF-α, IL-6, IL-17 production]:::outcome I --> J[Perpetuation of B and T cell activation]:::action J --> K[Chronic synovitis and pannus formation]:::urgent ``` ### Histological Features Explained | Feature | Mechanism | Hypersensitivity Type | |---------|-----------|----------------------| | Hyperplastic synovium | Chronic inflammation and angiogenesis | Type III | | Dense CD4+ T cell infiltrate | Th1 and Th17 cells recruited by chemokines (C5a, CXCL10) | Type III + Type IV | | B cells and plasma cells | Antibody production (RF, anti-CCP) | Type III | | Germinal centre-like structures | Local B cell activation and antibody class switching | Type III | | Activated macrophages | Recruited by C5a and activated by TNF-α | Type III | | Fibroblasts | Activated by TNF-α and IL-17; produce MMPs | Type III | **High-Yield:** The presence of **germinal centre-like structures** in the synovium indicates ongoing B cell activation and antibody production within the joint — a hallmark of Type III hypersensitivity. ### Why Type III, Not Type II? **Key Point:** Type II hypersensitivity involves antibody binding directly to cell surface antigens (e.g., Graves' disease, pemphigus). In RA, the antibodies (RF, anti-CCP) form **soluble immune complexes** that deposit in tissues and activate complement — the definition of Type III hypersensitivity. **Mnemonic:** **IIIC** — Type III = **I**mmune complexes, **I**n tissues, **I**nflammation, **C**omplement activation. ### The Secondary Type IV Component While the primary mechanism is Type III, RA also has a Type IV (cell-mediated) component: - **Th1 cells** produce IFN-γ, activating macrophages - **Th17 cells** produce IL-17, activating fibroblasts and osteoclasts - **CD8+ T cells** may contribute to synovial inflammation However, the **dominant and initiating** mechanism is Type III (immune complex-mediated). ### Clinical Correlations **Clinical Pearl:** The presence of **high-titre RF and anti-CCP antibodies** in this patient's serum indicates active immune complex formation. The **synovial biopsy findings** (lymphoid aggregates, germinal centres, activated macrophages) confirm local immune complex deposition and complement-driven inflammation. **Warning:** Do not confuse RA with: - **Type II hypersensitivity:** No direct antibody-to-cell-surface binding in RA - **Type IV hypersensitivity:** While present, it is secondary to immune complex-mediated inflammation - **Type I hypersensitivity:** No IgE involvement; mast cells are not the primary effectors [cite:Robbins 10e Ch 6; Harrison 21e Ch 329]